C. Dayen

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors

Alberto Vogrig, Marine Fouret, Bastien Joubert et al. · Neurology Neuroimmunology & Neuroinflammation · 2019 · 190 citations · Full text

Medicine, Neurology, Oncology +16

Major changes in lung cancer over the last ten years in France: The KBP-CPHG studies

Chrystèle Locher, D. Debieuvre, D. Coëtmeur et al. · Lung Cancer · 2013 · 109 citations

Medicine, Oncology, Pathology +16

Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial

Jean-Louis Pujol, A. Lavolé, Élisabeth Quoix et al. · Annals of Oncology · 2015 · 97 citations · Full text

Medicine, Oncology, Pharmacology +10

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

D. Debieuvre, Olivier Molinier, L. Falchero et al. · The Lancet Regional Health - Europe · 2022 · 76 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study

Alexis B. Cortot, Clarisse Audigier-Valette, Olivier Molinier et al. · European Journal of Cancer · 2020 · 72 citations

Medicine, Oncology, Pharmacology +12